AI Article Synopsis
- Clear cell renal cell carcinoma (ccRCC) is a common type of kidney cancer that can be influenced by certain RNA molecules called long non-coding RNAs (lncRNAs).
- The study looked at a specific lncRNA named HIF1A-AS2 to see how it affects ccRCC cells by promoting their growth and influencing other important proteins.
- The findings suggest that targeting HIF1A-AS2 could lead to new treatments for ccRCC by stopping the growth of cancer cells.
Article Abstract
Background: The most common urologic tumor in humans with the highest incidence rate is clear cell renal cell carcinoma (ccRCC). Long non-coding RNAs (lncRNAs) act as regulatory factors in several tumors. Here, we studied ccRCC regulated by hypoxia-inducible factor 1α (HIF1α)-antisense RNA 2 (AS2) or HIF1A-AS2.
Methods: We performed wound-healing, transwell, and CCK-8 assays by decreasing or increasing the HIF1A-AS2 expression in RCC cell lines. Western blotting and qRT-PCR were used to identify the expression of downstream genes of the HIF1A-AS2 pathway. Gli1 and HIF1A-AS2 relationship was assessed using RIP and RNA pull-down assays. Lastly, transcriptome sequencing was performed on kidney cancer cells that had been knocked down to find possible regulatory mechanisms.
Results: Our results suggest that high expression of HIF1A-AS2 may promote RCC cell proliferation and Gli1 expression as a downstream factor. Furthermore, they have physical binding sites and together regulate HIF1α to encourage the development of ccRCC. HIF1A-AS2 lncRNA may offer a new molecular target for ccRCC treatment.
Conclusion: lncRNA HIF1A-AS2 affects ccRCC development by regulating HIF1a expression through Gli1.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.prp.2023.154984 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!